Furthermore, the R-Spondin pathway, an activator of WNT signaling, emerges as a potential target, especially in cancers where RSPO translocations occur, offering avenues to inhibit cancer stem cell survival and proliferation [57,58,59,60]. This evidence concerns the gene RSPO1 and cancer.